Pre-demographic dividend vs Serbia: Prevalence of hypertension
Pre-demographic dividend
36.6%
in 2019
Serbia
46.1%
in 2019
Pre-demographic dividend rank
16th
Serbia rank
19th
Prevalence of hypertension over time
- Pre-demographic dividend
- Serbia
How they compare
Serbia currently reports 46.1% against 36.6% in Pre-demographic dividend, a difference of 9.5%.
That makes Serbia's figure about 1.3 times Pre-demographic dividend's.
Across all 30 years both countries report, Serbia has been ahead every year.
Pre-demographic dividend ranks 16th and Serbia ranks 19th of 43 groups.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Pre-demographic dividend | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 36.0% | 47.4% | 11.4% | Serbia |
| 2000s | 37.5% | 46.0% | 8.6% | Serbia |
| 2010s | 37.3% | 46.1% | 8.8% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, Pre-demographic dividend or Serbia?
- Serbia, at 46.1% against 36.6% in Pre-demographic dividend as of 2019.
- What is the difference in prevalence of hypertension between Pre-demographic dividend and Serbia?
- 9.5%, with Serbia ahead.
- How many years of comparable data are there for Pre-demographic dividend and Serbia?
- 30 years are reported by both, from 1990 to 2019.
- How do Pre-demographic dividend and Serbia rank globally for prevalence of hypertension?
- Pre-demographic dividend ranks 16th and Serbia ranks 19th of 43 groups.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension (% of adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension is the percentage of adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.